1.Hecker SJ, Reddy KR, Lomovskaya O, Griffith DC, Rubio-Aparicio D, Nelson K, Tsivkovski R, Sun D, Sabet M, Tarazi Z, Parkinson J, Totrov M, Boyer SH, Glinka TW, Pemberton OA, Chen Y, Dudley MN.. (2020) Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases., 63 (14):[PMID:32150407][10.1021/acs.jmedchem.9b01976]
2.Chen C, Oelschlaeger P, Wang D, Xu H, Wang Q, Wang C, Zhao A, Yang KW.. (2022) Structure and Mechanism-Guided Design of Dual Serine/Metallo-Carbapenemase Inhibitors., 65 (8.0):[PMID:35420040][10.1021/acs.jmedchem.2c00213]
3.Reddy KR, Parkinson J, Sabet M, Tarazi Z, Boyer SH, Lomovskaya O, Griffith DC, Hecker SJ, Dudley MN.. (2021) Selection of QPX7831, an Orally Bioavailable Prodrug of Boronic Acid β-Lactamase Inhibitor QPX7728., 64 (23.0):[PMID:34817182][10.1021/acs.jmedchem.1c01722]
4.Nagulapalli Venkata KC, Ellebrecht M, Tripathi SK.. (2021) Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1)., 225 [PMID:34391033][10.1016/j.ejmech.2021.113747]